Cerebral blood flow and glucose metabolism measured with positron emission tomography are decreased in human type 1 diabetes

Diabetes

Volumn 62, Issue 8, 2013, Pages 2898-2904

  Van Golen, Larissa W ^a   Huisman, Marc C ^a   Ijzerman, Richard G ^a   Hoetjes, Nikie J ^a   Schwarte, Lothar A ^a   Lammertsma, Adriaan A ^a   Diamant, Michaela ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN; INSULIN ASPART; ISOPHANE INSULIN; LIPID; WATER O 15; HUMAN GROWTH HORMONE;

ADULT; ARTICLE; BLOOD FLOWMETRY; BLOOD GLUCOSE METER; BLOOD PRESSURE; BODY MASS; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GRAY MATTER; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; MALE; MICROANGIOPATHY; MIDDLE AGED; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PET-MRI SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; YOUNG ADULT; ADOLESCENT; BRAIN; BRAIN CIRCULATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SCINTISCANNING; VASCULARIZATION;

ADOLESCENT; ADULT; BRAIN; CEREBROVASCULAR CIRCULATION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; GLUCOSE; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED;

EID: 84891707076     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-1159     Document Type: Article

References (58)

1. Bronson-Castain KW, Bearse MA Jr, Neuville J, et al. Early neural and vascular changes in the adolescent type 1 and type 2 diabetic retina. Retina 2012;32:92-102
2. Zerbini G, Bonfanti R, Meschi F, et al. Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes. Diabetes 2006;55:2620-2625
3. Srinivasan M, Herrero P, McGill JB, et al. The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus. J Am Coll Cardiol 2005;46:42-48
4. Brands AM, Kessels RP, de Haan EH, Kappelle LJ, Biessels GJ. Cerebral dysfunction in type 1 diabetes: Effects of insulin, vascular risk factors and blood-glucose levels. Eur J Pharmacol 2004;490:159-168
5. van Duinkerken E, Klein M, vanSchoonenboom NS, et al. Functional brain connectivity and neurocognitive functioning in patients with long-standing type 1 diabetes with and without microvascular complications: A magnetoencephalography study. Diabetes 2009;58:2335-2343
6. Musen G, Lyoo IK, Sparks CR, et al. Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 2006; 55:326-333
7. McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet 2012;379:2291-2299
8. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 1994;94:2511-2515
9. Clark MG. Impaired microvascular perfusion: A consequence of vascular dysfunction and a potential cause of insulin resistance in muscle. Am J Physiol Endocrinol Metab 2008;295:E732-E750
10. Bingham EM, Hopkins D, Smith D, et al. The role of insulin in human brain glucose metabolism: An 18fluoro-deoxyglucose positron emission tomography study. Diabetes 2002;51:3384-3390
11. Hirvonen J, Virtanen KA, Nummenmaa L, et al. Effects of insulin on brain glucose metabolism in impaired glucose tolerance. Diabetes 2011;60:443-447
12. Duckrow RB. Decreased cerebral blood flow during acute hyperglycemia. Brain Res 1995;703:145-150
13. Duckrow RB, Bryan RM Jr. Regional cerebral glucose utilization during hyperglycemia. J Neurochem 1987;48:989-993
14. Duckrow RB. Glucose transfer into rat brain during acute and chronic hyperglycemia. Metab Brain Dis 1988;3:201-209
15. Gjedde A, Crone C. Blood-brain glucose transfer: repression in chronic hyperglycemia. Science 1981;214:456-457
16. Iida H, Law I, Pakkenberg B, et al. Quantitation of regional cerebral blood flow corrected for partial volume effect using O-15 water and PET: I. Theory, error analysis, and stereologic comparison. J Cereb Blood Flow Metab 2000;20:1237-1251
17. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method. Ann Neurol 1979;6:371-388
18. Phelps ME. Positron computed tomography studies of cerebral glucose metabolism in man: Theory and application in nuclear medicine. Semin Nucl Med 1981;11:32-49
19. Reivich M, Kuhl D, Wolf A, et al. The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 1979;44:127-137
20. Frackowiak RS, Lenzi GL, Jones T, Heather JD. Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: Theory, procedure, and normal values. J Comput Assist Tomogr 1980;4:727-736
21. Ziegler D, Langen KJ, Herzog H, et al. Cerebral glucose metabolism in type 1 diabetic patients. Diabet Med 1994;11:205-209
22. Fanelli CG, Dence CS, Markham J, et al. Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes. Diabetes 1998;47:1444-1450
23. Bril V, Perkins BA. Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care 2002;25:2048-2052
24. van der Naalt J, Fidler V, van der Oosterhuis HJ. Vibration perception threshold, complaints and sensory examination in diabetic patients. Acta Neurol Scand 1991;83:297-300
25. Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002; 17:479-489
26. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(Suppl. 1):S208-S219
27. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351-356
28. Huisman MC, van Golen LW, Hoetjes NJ, Greuter HN, Schober P, IJzermanRG, Diamant M, LammertsmaAA. Cerebral blood flow and glucose metabolism in healthy volunteers measured using a high-resolution PET scanner. EJNMMI Res 2012;2:63
29. Hoekstra CJ, Paglianiti I, Hoekstra OS, et al. Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: An overview of different analytical methods. Eur J Nucl Med 2000;27:731-743
30. Boellaard R, van Lingen A, van Balen SC, Hoving BG, Lammertsma AA. Characteristics of a new fully programmable blood sampling device for monitoring blood radioactivity during PET. Eur J Nucl Med 2001;28: 81-89
31. van Velden FH, Kloet RW, van Berckel BN, et al. HRRT versus HR+ human brain PET studies: An interscanner test-retest study. J Nucl Med 2009;50: 693-702
32. van Velden FH, Kloet RW, van Berckel BN, Lammertsma AA, Boellaard R. Accuracy of 3-dimensional reconstruction algorithms for the high-resolution research tomograph. J Nucl Med 2009;50:72-80
33. Walker MD, Feldmann M, Matthews JC, et al. Optimization of methods for quantification of rCBF using high-resolution [(15)O]H(2)O PET images. Phys Med Biol 2012;57:2251-2271
34. Cízek J, Herholz K, Vollmar S, Schrader R, Klein J, Heiss WD. Fast and robust registration of PET and MR images of human brain. Neuroimage 2004;22:434-442
35. Svarer C, Madsen K, Hasselbalch SG, et al. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage 2005;24:969-979
36. Kety SS, Schmidt CF. The nitrous oxide method for the quantitative determination of cerebral blood flow in man: Theory, procedure, and normal values. J Clin Invest 1948;27:476-483
37. Suda S, Shinohara M, Miyaoka M, Lucignani G, Kennedy C, Sokoloff L. The lumped constant of the deoxyglucose method in hypoglycemia: Effects of moderate hypoglycemia on local cerebral glucose utilization in the rat. J Cereb Blood Flow Metab 1990;10:499-509
38. Wienhard K. Measurement of glucose consumption using [(18)F] fluorodeoxyglucose. Methods 2002;27:218-225
39. Schuier F, Orzi F, Suda S, Lucignani G, Kennedy C, Sokoloff L. Influence of plasma glucose concentration on lumped constant of the deoxyglucose method: Effects of hyperglycemia in the rat. J Cereb Blood Flow Metab 1990;10:765-773
40. Crone CC. The permeability of capillaries in various organs as determined by use of the 'indicator diffusion' method. Acta Physiol Scand 1963;58:292-305
41. Renkin EM. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 1959;197:1205-1210
42. Gutniak M, Blomqvist G, Widén L, Stone-Elander S, Hamberger B, Grill V. D-[U-11C]glucose uptake and metabolism in the brain of insulin-dependent diabetic subjects. Am J Physiol 1990;258:E805-E812
43. Avogaro A, Nosadini R, Doria A, et al. Substrate availability other than glucose in the brain during euglycemia and insulin-induced hypoglycemia in dogs. Metabolism 1990;39:46-50
44. Grill V, Gutniak M, Björkman O, et al. Cerebral blood flow and substrate utilization in insulin-treated diabetic subjects. Am J Physiol 1990;258: E813-E820
45. Mans AM, DeJoseph MR, Davis DW, Hawkins RA. Brain energy metabolism in streptozotocin-diabetes. Biochem J 1988;249:57-62
46. Duckrow RB, Beard DC, Brennan RW. Regional cerebral blood flow decreases during chronic and acute hyperglycemia. Stroke 1987;18: 52-58
47. Jimenez-Bonilla JF, Carril JM, Quirce R, Gomez-Barquin R, Amado JA, Gutierrez-Mendiguchia C. Assessment of cerebral blood flow in diabetic patients with no clinical history of neurological disease. Nucl Med Commun 1996;17:790-794
48. Quirce R, Carril JM, Jiménez-Bonilla JF, et al. Semi-quantitative assessment of cerebral blood flow with 99mTc-HMPAO SPET in type I diabetic patients with no clinical history of cerebrovascular disease. Eur J Nucl Med 1997;24:1507-1513
49. Salem MA, Matta LF, Tantawy AA, Hussein M, Gad GI. Single photon emission tomography (SPECT) study of regional cerebral blood flow in normoalbuminuric children and adolescents with type 1 diabetes. Pediatr Diabetes 2002;3:155-162
50. Cranston I, Marsden P, Matyka K, et al. Regional differences in cerebral blood flow and glucose utilization in diabetic man: The effect of insulin. J Cereb Blood Flow Metab 1998;18:130-140
51. Hasselbalch SG, Knudsen GM, Videbaek C, et al. No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans. Diabetes 1999;48:1915-1921
52. Reivich M, Alavi A, Wolf A, et al. Glucose metabolic rate kinetic model parameter determination in humans: The lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose. J Cereb Blood Flow Metab 1985;5:179-192
53. Sabri O, Hellwig D, Schreckenberger M, et al. Influence of diabetes mellitus on regional cerebral glucose metabolism and regional cerebral blood flow. Nucl Med Commun 2000;21:19-29
54. Wessels AM, Simsek S, Remijnse PL, et al. Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 2006;49:2474-2480
55. Pletzer B, Kronbichler M, Ladurner G, Nuerk HC, Kerschbaum H. Menstrual cycle variations in the BOLD-response to a number bisection task: implications for research on sex differences. Brain Res 2011;1420:37-47
56. Gur RE, Gur RC. Gender differences in regional cerebral blood flow. Schizophr Bull 1990;16:247-254
57. Andreason PJ, Zametkin AJ, Guo AC, Baldwin P, Cohen RM. Genderrelated differences in regional cerebral glucose metabolism in normal volunteers. Psychiatry Res 1994;51:175-183
58. Azari NP, Rapoport SI, Grady CL, et al. Gender differences in correlations of cerebral glucose metabolic rates in young normal adults. Brain Res 1992;574:198-208